| Product Code: ETC9388953 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Africa Patient Derived Xenograft (PDX) Models Market Overview |
3.1 South Africa Country Macro Economic Indicators |
3.2 South Africa Patient Derived Xenograft (PDX) Models Market Revenues & Volume, 2021 & 2031F |
3.3 South Africa Patient Derived Xenograft (PDX) Models Market - Industry Life Cycle |
3.4 South Africa Patient Derived Xenograft (PDX) Models Market - Porter's Five Forces |
3.5 South Africa Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 South Africa Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By Tumor Type, 2021 & 2031F |
3.7 South Africa Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 South Africa Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By Technique, 2021 & 2031F |
3.9 South Africa Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 South Africa Patient Derived Xenograft (PDX) Models Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in South Africa |
4.2.2 Growing demand for personalized medicine and targeted therapies |
4.2.3 Rising investments in research and development in the healthcare sector |
4.3 Market Restraints |
4.3.1 High costs associated with the development and maintenance of patient-derived xenograft (PDX) models |
4.3.2 Ethical concerns related to the use of animal models in research |
4.3.3 Limited awareness and adoption of PDX models in South Africa |
5 South Africa Patient Derived Xenograft (PDX) Models Market Trends |
6 South Africa Patient Derived Xenograft (PDX) Models Market, By Types |
6.1 South Africa Patient Derived Xenograft (PDX) Models Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 South Africa Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 South Africa Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Mice Models, 2021- 2031F |
6.1.4 South Africa Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Rat Models, 2021- 2031F |
6.2 South Africa Patient Derived Xenograft (PDX) Models Market, By Tumor Type |
6.2.1 Overview and Analysis |
6.2.2 South Africa Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Gastrointestinal Tumor Models, 2021- 2031F |
6.2.3 South Africa Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Lung Tumor Models, 2021- 2031F |
6.2.4 South Africa Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Haematological Tumor Models, 2021- 2031F |
6.3 South Africa Patient Derived Xenograft (PDX) Models Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 South Africa Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Preclinical Drug Development, 2021- 2031F |
6.3.3 South Africa Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Precision Medicine, 2021- 2031F |
6.3.4 South Africa Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Co-Clinical Trials, 2021- 2031F |
6.3.5 South Africa Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Basic Cancer Research, 2021- 2031F |
6.3.6 South Africa Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Biomarker Analysis, 2021- 2031F |
6.3.7 South Africa Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Oncology Research, 2021- 2031F |
6.4 South Africa Patient Derived Xenograft (PDX) Models Market, By Technique |
6.4.1 Overview and Analysis |
6.4.2 South Africa Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Heterotopic Implantation, 2021- 2031F |
6.4.3 South Africa Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Orthotropic Implantation, 2021- 2031F |
6.5 South Africa Patient Derived Xenograft (PDX) Models Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 South Africa Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Academic and Research Organizations, 2021- 2031F |
6.5.3 South Africa Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Contract Research Organizations, 2021- 2031F |
6.5.4 South Africa Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Pharmaceutical and Biotechnological Companies, 2021- 2031F |
6.5.5 South Africa Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Others, 2021- 2031F |
7 South Africa Patient Derived Xenograft (PDX) Models Market Import-Export Trade Statistics |
7.1 South Africa Patient Derived Xenograft (PDX) Models Market Export to Major Countries |
7.2 South Africa Patient Derived Xenograft (PDX) Models Market Imports from Major Countries |
8 South Africa Patient Derived Xenograft (PDX) Models Market Key Performance Indicators |
8.1 Number of collaborations between research institutions, pharmaceutical companies, and academic centers for PDX model research |
8.2 Percentage of research funding allocated to PDX model studies in South Africa |
8.3 Rate of adoption of PDX models in preclinical drug development studies within the country |
9 South Africa Patient Derived Xenograft (PDX) Models Market - Opportunity Assessment |
9.1 South Africa Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 South Africa Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By Tumor Type, 2021 & 2031F |
9.3 South Africa Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 South Africa Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By Technique, 2021 & 2031F |
9.5 South Africa Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By End User, 2021 & 2031F |
10 South Africa Patient Derived Xenograft (PDX) Models Market - Competitive Landscape |
10.1 South Africa Patient Derived Xenograft (PDX) Models Market Revenue Share, By Companies, 2024 |
10.2 South Africa Patient Derived Xenograft (PDX) Models Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here